CRISPR-Focused Companies Take Stock Dive

Shares in various companies using gene editing technologies fell earlier this week, after it was widely reported that CRISPR may raise the risk of cancer in edited cell populations.

The Minority Coalition for Precision Medicine

The story of Michael Friend and Shakir Cannon, the co-founders of the Minority Coalition for Precision Medicine, is an important story that’s far from over — and it may just change your perspective about the end-goal for genomics. 

Researchers Identify Cellular ‘Death Code’

Dying cells generally have two options: go quietly, or go out with a bang. The latter, while more conspicuous, is also mechanistically more mysterious. Now, scientists have pinpointed what they believe is the molecular “code” that unleashes this more violent variety of cell death.